Issue 6/2022
Content (11 Articles)
HDI Highlighter, The First Intelligent Tool to Screen the Literature on Herb–Drug Interactions
Anthony Cnudde, Patrick Watrin, Florence Souard
A Review of Population Pharmacokinetic Analyses of Linezolid
Enrique Bandín-Vilar, Laura García-Quintanilla, Ana Castro-Balado, Irene Zarra-Ferro, Miguel González-Barcia, Manuel Campos-Toimil, Víctor Mangas-Sanjuan, Cristina Mondelo-García, Anxo Fernández-Ferreiro
Filgotinib: A Clinical Pharmacology Review
Florence Namour, Kacey Anderson, Cara Nelson, Chantal Tasset
Population Pharmacokinetics of Cotadutide in Subjects with Type 2 Diabetes
Ye Guan, Neang Ly, Jing Li, Rosalinda H. Arends
Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study)
Vesa Cheng, Mohd H. Abdul-Aziz, Fay Burrows, Hergen Buscher, Young-Jae Cho, Amanda Corley, Eileen Gilder, Hyung-Sook Kim, Sung Yoon Lim, Shay McGuinness, Rachael Parke, Claire Reynolds, Sam Rudham, Steven C. Wallis, Susan A. Welch, John F. Fraser, Kiran Shekar, Jason A. Roberts
Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants
Vidya Perera, Grigor Abelian, Danshi Li, Zhaoqing Wang, Liping Zhang, Susan Lubin, Wei Chen, Akintunde Bello, Bindu Murthy
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Tingjie Guo, Alan Abdulla, Birgit C. P. Koch, Johan G. C. van Hasselt, Henrik Endeman, Jeroen A. Schouten, Paul W. G. Elbers, Roger J. M. Brüggemann, Reinier M. van Hest, Luca F Roggeveen, Lucas M. Fleuren, Nicole G. M. Hunfeld, Tim M. J. Ewoldt, Anouk E. Muller, Annemieke Dijkstra, Dylan W. de Lange, Emilie Gieling, Peter Pickkers, Jaap ten Oever
Population Pharmacokinetics of Rivaroxaban in Chinese Patients with Non-Valvular Atrial Fibrillation: A Prospective Multicenter Study
Feilong Zhang, Xuehai Chen, Tingting Wu, Nianxu Huang, Li Li, Dongdong Yuan, Jing Xiang, Na Wang, Wenjun Chen, Jinhua Zhang
Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients
Ibrahim El-Haffaf, Romain Guilhaumou, Lionel Velly, Amélie Marsot
An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
Eveline Wallenburg, Rob ter Heine, Jeroen A. Schouten, Jelmer Raaijmakers, Jaap ten Oever, Eva Kolwijck, David M. Burger, Peter Pickkers, Tim Frenzel, Roger J. M. Brüggemann
Correction to: Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
Prajakta Badri, Xuemin Jiang, Anna Borodovsky, Nader Najafan, Jae Kim, Valerie A. Clausen, Varun Goel, Bahru Habtemariam, Gabriel J. Robbie